GlassScriptPhysician profile
Vijaysinha A Mandhare
NPI 1891905287
$19,661.76
in general payments reported to CMS, 2019-2025
34 companies · $3,746 in 2025
The $3,746 reported for 2025 was more than what 91% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,049 · 2020: $902 · 2021: $1,246 · 2022: $4,805 · 2023: $5,581 · 2024: $2,333 · 2025: $3,746.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,986 · Travel and Lodging: $2,036 · Consulting Fee: $638.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,986.02 |
| Travel and Lodging | $2,035.73 |
| Consulting Fee | $637.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $9,067.13 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Vanta Adaptivestim |
| Boston Scientific Corporation | $4,213.45 | 2021-2025 | Wavewriter Alpha Prime 16, Artisan, General - Therapies |
| Stryker Corporation | $1,396.12 | 2025 | Mild Device Kit |
| Medtronic USA, INC. | $1,379.17 | 2019-2020 | |
| Abbott Laboratories | $1,267.85 | 2020-2025 | Eterna, Proclaim, Octrode |
| Saluda Medical Americas, INC. | $358.32 | 2024-2025 | Evoke |
| Si-Bone, INC. | $309.04 | 2021-2025 | |
| Nalu Medical, INC. | $249.81 | 2021-2023 | Nalu Neurostimulation System |
| Collegium Pharmaceutical, INC. | $248.48 | 2019-2025 | Belbuca |
| Scilex Pharmaceuticals INC. | $144.51 | 2019-2023 | Ztlido |
| Abbvie INC. | $100.00 | 2021 | |
| Arbor Pharmaceuticals, INC. | $99.50 | 2019-2020 | |
| Fidia Pharma USA INC. | $96.90 | 2019-2022 | |
| Forte Bio-Pharma LLC | $74.60 | 2025 | Prolate, Tanlor, Nalocet |
| Curonix LLC | $71.37 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries LP | $70.99 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $47.92 | 2020-2022 | |
| Spinal Simplicity, LLC | $43.37 | 2025 | Ha Minuteman G3-R |
| Spr Therapeutics, INC | $40.00 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $39.29 | 2019-2020 | |
| Azurity Pharmaceuticals, INC. | $39.24 | 2023 | Horizant |
| Nevro Corp. | $39.15 | 2021-2024 | Senza |
| Virtus Pharmaceuticals LLC | $37.92 | 2024 | Levorphanol Tartrate |
| Amgen INC. | $28.90 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $28.61 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $24.95 | 2025 | |
| Biodelivery Sciences International, INC. | $24.87 | 2019 | |
| Sentynl Therapeutics, INC. | $24.84 | 2019 | |
| Grt US Holding, INC. | $23.80 | 2022 | |
| Bioventus LLC | $20.30 | 2025 | Xcell |
| Depuy Synthes Sales INC. | $13.58 | 2019 | |
| Daiichi Sankyo INC. | $13.39 | 2019 | |
| Stimwave Technologies Incorporated | $12.60 | 2019 | |
| Shionogi INC | $11.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vijaysinha Mandhare listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.